-DOCSTART- -X- O
Programmed -X- _ B-Patient
ribosomal -X- _ I-Patient
frameshifting -X- _ I-Patient
is -X- _ O
a -X- _ O
translational -X- _ O
recoding -X- _ O
mechanism -X- _ O
commonly -X- _ O
used -X- _ O
by -X- _ O
RNA -X- _ O
viruses -X- _ O
to -X- _ O
express -X- _ O
two -X- _ O
or -X- _ O
more -X- _ O
proteins -X- _ O
from -X- _ O
a -X- _ O
single -X- _ O
mRNA -X- _ O
at -X- _ O
a -X- _ O
fixed -X- _ O
ratio. -X- _ O
An -X- _ O
essential -X- _ O
element -X- _ O
in -X- _ O
this -X- _ O
process -X- _ O
is -X- _ O
the -X- _ O
presence -X- _ O
of -X- _ O
an -X- _ O
RNA -X- _ O
secondary -X- _ O
structure -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
a -X- _ O
pseudoknot -X- _ O
or -X- _ O
a -X- _ O
hairpin -X- _ O
, -X- _ O
located -X- _ O
downstream -X- _ O
of -X- _ O
the -X- _ O
slippery -X- _ O
sequence. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
have -X- _ O
tested -X- _ O
the -X- _ O
efficiency -X- _ B-Outcome
of -X- _ O
RNA -X- _ B-Intervention
oligonucleotides -X- _ I-Intervention
annealing -X- _ I-Intervention
downstream -X- _ I-Intervention
of -X- _ I-Intervention
the -X- _ I-Intervention
slippery -X- _ I-Intervention
sequence -X- _ I-Intervention
to -X- _ O
induce -X- _ B-Patient
frameshifting -X- _ I-Patient
in -X- _ I-Patient
vitro. -X- _ I-Patient
Maximal -X- _ B-Outcome
frameshifting -X- _ I-Outcome
was -X- _ I-Outcome
observed -X- _ I-Outcome
with -X- _ I-Outcome
oligonucleotides -X- _ I-Outcome
of -X- _ I-Outcome
12â€“18 -X- _ I-Outcome
nt. -X- _ I-Outcome
Antisense -X- _ I-Outcome
oligonucleotides -X- _ I-Outcome
bearing -X- _ I-Outcome
locked -X- _ I-Outcome
nucleid -X- _ I-Outcome
acid -X- _ I-Outcome
( -X- _ I-Outcome
LNA -X- _ I-Outcome
) -X- _ I-Outcome
modifications -X- _ I-Outcome
also -X- _ I-Outcome
proved -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
efficient -X- _ I-Outcome
frameshift-stimulators -X- _ I-Outcome
in -X- _ I-Outcome
contrast -X- _ I-Outcome
to -X- _ I-Outcome
DNA -X- _ I-Outcome
oligonucleotides. -X- _ I-Outcome
The -X- _ I-Outcome
number -X- _ I-Outcome
, -X- _ I-Outcome
sequence -X- _ I-Outcome
and -X- _ I-Outcome
location -X- _ I-Outcome
of -X- _ I-Outcome
LNA -X- _ I-Outcome
bases -X- _ I-Outcome
in -X- _ I-Outcome
an -X- _ I-Outcome
otherwise -X- _ I-Outcome
DNA -X- _ I-Outcome
oligonucleotide -X- _ I-Outcome
have -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
carefully -X- _ I-Outcome
manipulated -X- _ I-Outcome
to -X- _ I-Outcome
obtain -X- _ I-Outcome
optimal -X- _ I-Outcome
levels -X- _ I-Outcome
of -X- _ I-Outcome
frameshifting. -X- _ I-Outcome
Our -X- _ O
data -X- _ O
favor -X- _ O
a -X- _ O
model -X- _ O
in -X- _ O
which -X- _ O
RNA -X- _ B-Outcome
stability -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
entrance -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
ribosomal -X- _ I-Outcome
tunnel -X- _ I-Outcome
is -X- _ I-Outcome
the -X- _ I-Outcome
major -X- _ I-Outcome
determinant -X- _ I-Outcome
of -X- _ I-Outcome
stimulating -X- _ I-Outcome
slippage -X- _ I-Outcome
rather -X- _ I-Outcome
than -X- _ I-Outcome
a -X- _ I-Outcome
specific -X- _ I-Outcome
three- -X- _ I-Outcome
dimensional -X- _ I-Outcome
structure -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
stimulating -X- _ I-Outcome
RNA -X- _ I-Outcome
element -X- _ I-Outcome
. -X- _ O

